Geographic approaches to quantifying the risk environment: Drug-related law enforcement and access to syringe exchange programmes

International Journal of Drug Policy

Volumn 20, Issue 3, 2009, Pages 217-226

  Cooper, Hannah L F ^a   Bossak, Brian ^a   Tempalski, Barbara ^b   Des Jarlais, Don C ^c   Friedman, Samuel R ^b,d  

^a EMORY UNIVERSITY   (United States)

^b NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

^c BETH ISRAEL MEDICAL CENTER   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Drug related law enforcement; Geographic methods; HIV; Injection drug use; Risk environment; Syringe exchange programmes

Indexed keywords

ARTICLE; CRIMINAL JUSTICE; DISEASE TRANSMISSION; DRUG DEPENDENCE; GEOGRAPHIC DISTRIBUTION; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; LAW ENFORCEMENT; PRIORITY JOURNAL; RISK; RISK REDUCTION; SOCIAL ENVIRONMENT; SYRINGE;

EID: 59649084328     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugpo.2008.08.008     Document Type: Note

References (71)

1. Aceijas C., Hickman M., Donoghoe M., Burrows D., and Stuikyte R. Access and coverage of needle and syringe programmes (NSP) in Central and Eastern Europe and Central Asia. Addiction 102. (2007) 1244-1250
2. Austin S., Melly S., Sanchez B., Patel A., Buka S., and Gortmaker S. Clustering of fast-food restaurants around schools: A novel application of spatial statistics to the study of food environments. American Journal of Public Health 95 9 (2005) 1575-1581
3. Bamford E., Dunne L., Taylor D., Symon B., Hugo G., and Wilkinson D. Accessibility to general practitioners in rural South Australia. A case study using geographic information systems technology. Medical Journal of Australia 171 11-12 (1999) 614-616
4. Bastos F.I., and Strathdee S.A. Evaluating the effectiveness of syringe exchange programmes: Current issues and future prospects. Social Science & Medicine 51 (2000) 1771-1782
5. Berkman L.F., and Kawachi I. Social epidemiology (2000), Oxford University Press, New York
6. Blankenship K.M., Bray S.J., and Merson M.H. Structural interventions in public health. Aids 14 Suppl. 1 (2000) S11-S21
7. Bluthenthal R., Do D., Finch B., Martinez A., Edlin B., and Kral A. Community characteristics associated with HIV risk among injection drug users in the San Francisco Bay Area: A multilevel analysis. Journal of Urban Health 84 5 (2007) 653-666
8. Bluthenthal R.N., Lorvick J., Kral A.H., Erringer E.A., and Kahn J.G. Collateral damage in the war on drugs: Injection drug use. International Journal of Drug Policy 10 (1999) 25-38
9. Buchanan D., Shaw S., Teng W., Hiser P., and Singer M. Neighborhood differences in patterns of syringe access, use, and discard among injection drug users: Implications for HIV outreach and prevention education. Journal of Urban Health 80 3 (2003) 438-454
10. Cooper H., Friedman S.R., Tempalski B., and Friedman R. Residential segregation and the prevalence of injection drug use among black adult residents of US metropolitan areas. American Journal of Public Health 97 2 (2007) 344-352
11. Cooper H., Moore L., Gruskin S., and Krieger N. The impact of a police drug crackdown on drug injectors' ability to practice harm reduction: A qualitative study. Social Science & Medicine 61 3 (2005) 673-684
12. Cromley E.K., and McClafferty S. GIS and public health (2002), The Guilford Press, New York
13. Davis C.S., Burris S., Kraut-Becher J., Lynch K.G., and Metzger D. Effects of an intensive street-level police intervention on syringe exchange program use in Philadelphia, PA. American Journal of Public Health 95 2 (2005) 2333-2236
14. Des Jarlais D.C. Structural interventions to reduce HIV transmission among injecting drug users. Aids 14 Suppl. 1 (2000) S41-S46
15. Des Jarlais D.C., Diaz T., Perlis T., Vlahov D., Maslow C., Latka M., et al. Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. American Journal of Epidemiology 157 5 (2003) 467-471
16. Diez-Roux A. Places, people, and health. American Journal of Epidemiology 155 6 (2002) 516519
17. Diez-Roux A. The examination of neighborhood effects on health: conceptual and methodological issues related to the presence of multiple levels of organization. In: Kawachi I., and Berkman L.F. (Eds). Neighborhoods and health (2003), Oxford University Press, New York 45-64
18. Diez-Roux A. The study of group-level factors in epidemiology: Rethinking variables, study designs, and analytical approaches. Epidemiologic Reviews 26 (2004) 104-111
19. Diez-Roux A. Neighborhoods and health: Where are we and where do we go from here?. Revue d'epidemiologie et de sante publique 55 1 (2007) 13-21
20. ESRI (2006). ArcInfo software program version 9.2.
21. Friedman S.R., Cooper H.L., Tempalski B., Keem M., Friedman R., Flom P.L., et al. Relationships of deterrence and law enforcement to drug-related harms among drug injectors in US metropolitan areas. Aids 20 1 (2006) 93-99
22. Fuller C.M., Borrell L., Latkin C., Galea S., Ompad D.C., Strathdee S.A., et al. Effects of race, neighborhood, and social network on age at initiation of injection drug use. American Journal of Public Health 95 4 (2005) 689-695
23. Fyfe N. Space, time, and policing: Toward a contexual understanding of police work. Environment and Planning D: Society and Space 10 (1992) 469-481
24. Grau L., Arevalo S., Catchpool C., and Heimer R. Expanding harm reduction services through a wound and abscess clinic. American Journal of Public Health 92 12 (2002) 1915-1917
25. Greene L. Policing places with drug problems (1996), Sage Publications, Thousand Oaks, CA
26. Grund J.P., Heckathorn D., and Anthony D. In Eastern Connecticut, IDUs purchase syringes from pharmacies but don't carry syringes. Journal of Acquired Immune Deficiency Syndromes 10 (1995) 105
27. Haynes R., Bentham G., Lovett A., and Gale S. Effects of distances to hospital and GP surgery on hospital inpatient episodes, controlling for needs and provision. Social Science & Medicine 49 (2002) 425-443
28. Hembree C., Galea S., Ahern J., Tracy M., Markham Piper T., Miller J., et al. The urban built environment and overdose mortality in New York City neighborhoods. Health and Place 11 (2005) 147-156
29. Human Rights Watch. Targeting Blacks: drug law enforcement and race in the United States (2008), Human Rights Watch, New York
30. Huo D., Bailey S.L., Hershow R.C., and Ouellet L. Drug use and HIV risk practices of secondary and primary needle exchange users. Aids Education & Prevention 17 2 (2005) 170-184
31. Khan A. An integrated approach to measuring potential spatial access to health care services. Socioeconomic Planning Science 26 4 (1992) 275-287
32. Krieger N. Epidemiology and the web of causation: Has anyone seen the spider?. Social Science & Medicine 39 7 (1994) 887-903
33. Ksobiech K. A meta-analysis of needle sharing, lending, and borrowing behaviors of needle exchange program attenders. Aids Education & Prevention 15 3 (2003) 257-268
34. Latkin C., Williams C.T., Wang J., and Curry A.D. Neighborhood social disorder as a determinant of drug injection behaviors: A structural equation modelling approach. Health Psychology 24 1 (2005) 96-100
35. Lawson A.B. Statistical methods in spatial epidemiology (2001), John Wiley & Sons, Ltd., New York
36. Lorvick J., Bluthenthal R.N., Scott A., Gilbert M.L., Riehman K.S., Anderson R.L., et al. Secondary syringe exchange among users of 23 California syringe exchange programs. Substance Use & Misuse 41 (2006) 856-882
37. Love D., and Lindquist P. The geographical accessibility of hospitals to the aged: A geographic information systems analysis within Illinois. Health Services Research 29 6 (1995) 629-651
38. Luo W., and Wang F. Measures of spatial accessibility of health care in a GIS environment: Synthesis and a case study in the Chicago region. Environment and Planning B: Planning and Design 30 (2003) 865-884
39. Maas B., Fairbairn N., Kerr T., Li K., Montaner J.S.G., and Wood E. Neighborhood and HIV infection among IDU: Place of residence independently predicts HIV infection among a cohort of injection drug users. Health and Place 13 (2007) 432-439
40. Macintyre S., and Ellaway A. Neighborhoods and health: an overview. In: Kawachi I., and Berkman L.F. (Eds). Neighborhoods and health (2003), Oxford University Press, New York 20-44
41. Maher L., and Dixon D. Policing and public health: Law enforcement and harm reduction in a street-level drug market. British Journal of Criminology 39 4 (1999) 488-512
42. McClafferty S. GIS and health care. Annual Review of Public Health 24 (2003) 25-42
43. McClafferty S., and Grady S. Prenatal care need and access: A GIS analysis. Journal of Medical Systems 28 3 (2004) 321-333
44. McClafferty S., and Grady S. Immigration and geographic access to prenatal clinics in Brooklyn, NY: A geographic information systems analysis. American Journal of Public Health 95 4 (2005) 638-640
45. Moore M. An analytic view of drug control policies (1990), Harvard University, Cambridge, MA
46. Navarro V., and Muntaner C. Political and economic determinants of population health and well-being (2004), Baywood Publishing Company, Inc., Amityville, NY
47. Neckerman K.M., and Torche F. Inequality: Causes and consequences. Annual Review of Sociology 33 (2007) 335-357
48. Phillips D. Health and health care in the third world (1990), Longman Scientific and Technical, Essex, England
49. Pollack H.A., Khoshnood K., Blankenship K.M., and Altice F.L. The impact of needle exchange based health services on emergency department use. Journal General Internal Medicine 17 (2002) 341-348
50. Raudenbush S., and Bryk A. Hierarchical linear models: applications and data analysis methods (2002), Sage, London, UK
51. Rhodes T. The 'risk environment': A framework for understanding and reducing drug-related harm. International Journal of Drug Policy 13 2 (2002) 85-94
52. Rhodes T., Mikhailova L., Sarang A., Lowndes C., Rylkov A., Khutorskoy M., et al. Situational factors influencing drug injecting, risk reduction and syringe exchange in Togliatti City, Russian Federation: A qualitative study of micro risk environment. Social Science & Medicine 57 1 (2003) 39-54
53. Rhodes T., Singer M., Bourgois P., Friedman S.R., and Strathdee S.A. The social structural production of HIV risk among injecting drug users. Social Science & Medicine 61 5 (2005) 1026-1044
54. Rockwell R., Des Jarlais D.C., Friedman S.R., Perlis T.E., and Paone D. Geographic proximity, policy and utilization of syringe exchange programmes. Aids Care 11 4 (1999) 437-442
55. Rothenberg R.B., Muth S., Malone S., Potterat J., and Woodhouse D.E. Social and geographic distance in HIV risk. Sexually Transmitted Diseases 32 8 (2005) 506-512
56. Shannon K., Rusch M., Shoveller J., Alexson D., Gibson K., Tyndall M., et al. Mapping violence and policing as an environmental-structural barrier to health service and syringe availability among substance-using women in street-level sex work. International Journal of Drug Policy 19 (2008) 140-147
57. Sharma M., Burrows D., and Bluthenthal R.N. Coverage of HIV prevention programmes for injection drug users: Confusions, aspirations, definitions and ways forward. International Journal of Drug Policy 18 (2007) 92-98
58. Small W., Kerr T., Charette J., Schechter M., and Spittal P. Impacts of intensified police activity on injection drug users: Evidence from an ethnographic investigation. International Journal of Drug Policy 17 (2006) 85-95
59. Smeeding T. Public policy, economic inequality, and poverty: The United States in comparative perspective. Social Science Quarterly 85 S1 (2005) 955-983
60. Sumartojo E. Structural factors in HIV prevention: Concepts, examples, and implications for research. Aids 14 Suppl. 1 (2000) S2-S10
61. Sumartojo E., Doll L., Holtgrave D., Gayle H., and Merson M.H. Enriching the mix: Incorporating structural factors into HIV prevention. Aids Suppl. 1 (2000) S1-S2
62. Susser M., and Susser E. Choosing a future for epidemiology. I. Eras and paradigms. American Journal of Public Health 86 5 (1996) 668-673
63. Susser M., and Susser E. Choosing a future for epidemiology. II. From black box to Chinese boxes and eco-epidemiology. American Journal of Public Health 86 5 (1996) 674-677
64. Tempalski B., Cooper H.L., Friedman S.R., Des Jarlais D.C., Brady J.E., and Gostnell K. Correlates of syringe coverage for heroin injection in 35 large metropolitan areas in the US in which heroin is the dominant injected drug. International Journal of Drug Policy 19 Suppl. 1 (2008) S47-S58
65. Thorpe L., Bailey S.L., DeZheng H., Monterroso E.R., and Ouellet L.J. Injection-related risk behaviors in young urban and suburban injection drug users in Chicago (1997-1999). Journal of Acquired Immune Deficiency Syndromes 27 1 (2001) 71-78
66. US General Accounting Office. Health care shortage areas designations report to congressional committees (1995), US GAO, Washington, DC
67. Vernez Moudon A. The Effectiveness of safe needle disposal programs for injection drug users: a spatial and temporal analysis (2007), RWJ SAPRP, Montreal, Canada
68. Wodak A., and Cooney A. Effectiveness of sterile needle and syringe programmes. International Journal of Drug Policy 16 Supplement (2005) S31-S44
69. Wood E., Kerr T., Small W., Jones J., Schechter M., and Tyndall M. The impact of police presence on access to needle exchange programs. Journal of Acquired Immune Deficiency Syndromes 34 1 (2003) 116-118
70. Wood E., Spittal P., Small W., Kerr T., Li K., Hogg R., et al. Displacement of Canada's largest public illicit drug market in response to a police crackdown. Canadian Medical Association Journal 170 10 (2004) 1551-1556
71. Yang D.-H., Goerge R., and Mullner R. Comparing GIS-based methods of measuring spatial accessibility to health services. Journal of Medical Systems 30 1 (2006) 23-32